AXV-101

· Axovia Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AXV-101, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human, Dose Escalation Trial of AXV-101 in BBS1-Related Retinal Degeneration [EARLY_Phase 1]